Showing results (11-20 of 223) with videos related to
Sort By:
Pageof 23
Investigational New Drugs|November 13, 2010
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primatesAeRang Kim, Cindy McCully, Rafael Cruz, et al.Cancer Chemotherapy and Pharmacology|September 13, 2014
Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastomaAmi V Desai, Elizabeth Fox, L Mary Smith, et al.Cancer Chemotherapy and Pharmacology|October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumorsElizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumorsKatherine E Warren, Alberta A Aikin, Madeleine Libucha, et al.Pediatric Blood & Cancer|August 1, 2012
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsMeredith K Chuk, Alberta Aikin, Trish Whitcomb, et al.Cancer Chemotherapy and Pharmacology|December 30, 2016
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot ConsortiumFrank M Balis, Patrick A Thompson, Yael P Mosse, et al.Journal of the National Cancer Institute|May 13, 2010
Pediatric phase I trial design using maximum target inhibition as the primary endpointHolly Meany, Frank M Balis, Alberta Aikin, et al.Nucleic Acids Research|April 20, 2004
Use of pteridine nucleoside analogs as hybridization probesMary E Hawkins, Frank M BalisClinical Biochemistry|December 20, 2021
Age-dependent reference intervals in children for the disialoganglioside, GD2, a circulating tumor biomarker for the childhood cancer, neuroblastomaChristine M Busch, Frank M BalisCancer Chemotherapy and Pharmacology|June 28, 2011
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primatesLeigh Marcus, Robert Murphy, Elizabeth Fox, et al.Pageof 23